BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2426418)

  • 1. Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
    McClelland RA; Berger U; Miller LS; Powles TJ; Coombes RC
    J Clin Oncol; 1986 Aug; 4(8):1171-6. PubMed ID: 2426418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer.
    McClelland RA; Berger U; Miller LS; Powles TJ; Jensen EV; Coombes RC
    Cancer Res; 1986 Aug; 46(8 Suppl):4241s-4243s. PubMed ID: 2425943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
    Kiang DT; Kollander R
    J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples.
    Jonat W; Maass H; Stegner HE
    Cancer Res; 1986 Aug; 46(8 Suppl):4296s-4298s. PubMed ID: 2425947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
    Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
    Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].
    Tominaga T
    Gan No Rinsho; 1983 May; 29(6):628-31. PubMed ID: 6308307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.
    DeSombre ER; Thorpe SM; Rose C; Blough RR; Andersen KW; Rasmussen BB; King WJ
    Cancer Res; 1986 Aug; 46(8 Suppl):4256s-4264s. PubMed ID: 2425944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine therapy of breast cancer].
    Jonat W; Maass H
    Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biochemical and immunoenzymatic macromethods and a new immunocytochemical micromethod for assaying estrogen receptors in human breast carcinomas.
    Devleeschouwer N; Faverly D; Kiss R; Legros N; de Launoit Y; Ryckaert C; Andry M; Lenglet G; Paridaens R; Gompel CM
    Acta Cytol; 1988; 32(6):816-24. PubMed ID: 2462316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoperoxidase localization of estrogen receptors in human brest carcinoma.
    Garancis JC; Miller LS; Tomita JT; Tieu TM; Clowry LJ
    Cancer Detect Prev; 1983; 6(1-2):235-9. PubMed ID: 6192919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1782-6. PubMed ID: 2412495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
    Masood S; Lu L; Rodenroth N
    Mod Pathol; 1990 Nov; 3(6):724-8. PubMed ID: 1702213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hormones on proliferation of ER-positive cells and ER-negative cells of human breast cancer (MCF-7).
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Ashikari A; Miyazaki I
    Oncology; 1990; 47(1):19-24. PubMed ID: 2137212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
    Kommoss F; Pfisterer J; Idris T; Giese E; Sauerbrei W; Schäfer W; Thome M; Pfleiderer A
    Anal Quant Cytol Histol; 1994 Jun; 16(3):203-10. PubMed ID: 7916848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
    Petru E; Schmähl D
    Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.